MWM
UTHR icon

MOKAN Wealth Management’s United Therapeutics UTHR Stock Holding History

MOKAN Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,131
Closed -$670K – 123
2026
Q1 		$670K Buy
1,131
+583
+106% +$290K 0.3% 64
2025
Q4 		$266K Buy
+548
New +$255K 0.12% 92

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

MOKAN Wealth Management's UTHR Position: Q2 2026 in Review

MOKAN Wealth Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 1,131 shares — an estimated $670K sold.

MOKAN Wealth Management first reported a position in UTHR in Q4 2025 and held it in 2 quarters. The position peaked at $670K in Q1 2026. 285 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • MOKAN Wealth Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MOKAN Wealth Management sold 1,131 United Therapeutics shares in Q2 2026, an estimated $670K.
  • MOKAN Wealth Management first reported a position in United Therapeutics in Q4 2025 and held it in 2 quarters.
  • MOKAN Wealth Management's United Therapeutics position peaked at $670K in Q1 2026.
  • 285 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on MOKAN Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.